{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:02:48Z","timestamp":1789545768906,"version":"build-2803163510"},"reference-count":40,"publisher":"Aboutscience Srl","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Circ Biomark"],"abstract":"<jats:p>Introduction: Breast cancer (BC) remains a leading cause of cancer-related mortality among women worldwide.Despite advances in molecular diagnostics, reliable non-invasive biomarkers for early detection and disease staging remain limited. Circulating microRNAs (miRNAs) are promising epigenetic regulators involved in tumor development and progression.Methods: Determination of plasma miRNA (1271-5p, miR-646, and miR-135a-5p) differential expression profiles in an Egyptian cohort comprising 111 BC patients (stages 0\u2013IV), 25 benign breast disease cases, and 24 healthy controls. Their diagnostic and stage-specific performance was assessed alongside integrative analyses of predicted and validated biological targets with network construction.Results: miR-1271-5p was downregulated in benign tumors but overexpressed across all BC stages. miR-646 was generally downregulated, with a notable increase in stage III, whereas miR-135a-5p was elevated in benign and early-stage disease before declining in metastatic stage IV. ROC analyses demonstrated strong discriminatory performance, with miR-1271-5p distinguishing early-stage BC from controls and benign lesions, miR-646 separating benign\/early malignant cases from controls, and miR-135a-5p identifying metastatic disease. Combined miRNA panels improved discrimination between malignant and non-malignant samples and between early and advanced stages. Integrative analyses identified putative regulation of ZEB1, CCND2, FOXN3, and RUNX2, while TP53TG1, ZFAS1, XIST, and MALAT1 emerged as potential interaction hubs. Functional enrichment suggested involvement in AMPK, FOXO, SUMOylation, TP53-mediated, and immune-related pathways.Conclusions: Circulating miR-1271-5p, miR-646, and miR-135a-5p, individually and in combination, show promise as non-invasive diagnostic and stage-specific biomarkers for BC. Integrative network analyses provide insight into their putative roles in BC progression.<\/jats:p>","DOI":"10.33393\/jcb.2026.3840","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:12:59Z","timestamp":1789542779000},"page":"47-57","source":"Crossref","is-referenced-by-count":0,"title":["Circulating miRNAs (135a-5p, 646 AND 1271-5P) in breast cancer diagnosis and staging: integrative network and functional analysis"],"prefix":"10.33393","volume":"15","author":[{"given":"Asmaa","family":"Abdel-Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Barsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Abo-Elmatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Gibriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18642","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"20740","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. https:\/\/doi.org\/10.3322\/caac.21834 PMID:38572751","DOI":"10.3322\/caac.21834"},{"key":"20741","doi-asserted-by":"crossref","unstructured":"Abdel-Fadeel NA, Zanaty MM, Kamal AM, et al. Childhood psychological trauma and psychiatric comorbidity in patients with breast cancer. Egypt J Hosp Med. 2022;88(1):2788-2794. https:\/\/doi.org\/10.21608\/ejhm.2022.241954","DOI":"10.21608\/ejhm.2022.241954"},{"key":"20742","doi-asserted-by":"crossref","unstructured":"Santiago L, Adrada BE, Huang ML, et al. Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. Breast Cancer Res Treat. 2017;166(1):29-39. https:\/\/doi.org\/10.1007\/s10549-017-4401-7 PMID:28730339","DOI":"10.1007\/s10549-017-4401-7"},{"key":"20743","doi-asserted-by":"crossref","unstructured":"Shao Y, Sun X, He Y, et al. Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer. PLoS One. 2015;10(7):e0133830. https:\/\/doi.org\/10.1371\/journal.pone.0133830 PMID:26207909","DOI":"10.1371\/journal.pone.0133830"},{"key":"20744","doi-asserted-by":"crossref","unstructured":"El-Maraghy SA, Adel O, Zayed N, et al. Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis. J Adv Res. 2019;22:57-66. https:\/\/doi.org\/10.1016\/j.jare.2019.12.002 PMID:31956442","DOI":"10.1016\/j.jare.2019.12.002"},{"key":"20745","doi-asserted-by":"crossref","unstructured":"Gibriel AA, Ismail MF, Sleem H, et al. Diagnosis and staging of HCV associated fibrosis, cirrhosis and hepatocellular carcinoma with target identification for miR-650, 552-3p, 676-3p, 512-5p and 147b. Cancer Biomark. 2022;34(3):413-430. https:\/\/doi.org\/10.3233\/CBM-210456 PMID:35094988","DOI":"10.3233\/CBM-210456"},{"key":"20746","doi-asserted-by":"crossref","unstructured":"Zhang H, Wang M, Lang Z, et al. MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3. Clinics (Sao Paulo). 2022;77:100115. https:\/\/doi.org\/10.1016\/j.clinsp.2022.100115 PMID:36228497","DOI":"10.1016\/j.clinsp.2022.100115"},{"key":"20747","doi-asserted-by":"crossref","unstructured":"Bahar NAA, Al-Ouqaili MTS, Talib NM. Improving the diagnosis and follow-up of chronic myeloid leukemia using conventional and molecular techniques. J Clin Lab Anal. 2025;39(5):e70001. https:\/\/doi.org\/10.1002\/jcla.70001 PMID:39927600","DOI":"10.1002\/jcla.70001"},{"key":"20748","doi-asserted-by":"crossref","unstructured":"Fan G, Jiao J, Shen F, et al. Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR-1271-5p and upregulating FRS2. Thorac Cancer. 2020;11(8):2178-2187. https:\/\/doi.org\/10.1111\/1759-7714.13525 PMID:32515146","DOI":"10.1111\/1759-7714.13525"},{"key":"20749","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang Z, Cheng K, et al. FAM201A promotes cervical cancer progression and metastasis through miR-1271-5p\/flotillin-1 axis targeting-induced Wnt\/\u03b2-catenin pathway. J Oncol. 2022;2022:1123839. https:\/\/doi.org\/10.1155\/2022\/1123839 PMID:36226250","DOI":"10.1155\/2022\/1123839"},{"key":"20750","doi-asserted-by":"crossref","unstructured":"Liu N, Feng S, Li H, et al. Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis. J Cancer Res Clin Oncol. 2020;146(2):367-379. https:\/\/doi.org\/10.1007\/s00432-020-03127-8 PMID:31953613","DOI":"10.1007\/s00432-020-03127-8"},{"key":"20751","doi-asserted-by":"crossref","unstructured":"Zhang B, Chen J, Cui M, et al. LncRNA ZFAS1\/miR-1271-5p\/HK2 promotes glioma development through regulating proliferation, migration, invasion and apoptosis. Neurochem Res. 2020;45(12):2828-2839. https:\/\/doi.org\/10.1007\/s11064-020-03131-x PMID:32964288","DOI":"10.1007\/s11064-020-03131-x"},{"key":"20752","doi-asserted-by":"crossref","unstructured":"Diao H, Xu X, Zhao B, et al. miR 135a 5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer. Mol Med Rep. 2021;24(1):528. https:\/\/doi.org\/10.3892\/mmr.2021.12167 PMID:34036386","DOI":"10.3892\/mmr.2021.12167"},{"key":"20753","doi-asserted-by":"crossref","unstructured":"Guo LM, Ding GF, Xu W, et al. MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10. Cancer Biol Ther. 2018;19(11):973-983. https:\/\/doi.org\/10.1080\/15384047.2018.1450112 PMID:29580143","DOI":"10.1080\/15384047.2018.1450112"},{"key":"20754","doi-asserted-by":"crossref","unstructured":"Luo W, Sun C, Zhou J, et al. miR-135a-5p functions as a glioma proliferation suppressor by targeting tumor necrosis factor receptor-associated factor 5 and predicts patients' prognosis. Am J Pathol. 2019;189(1):162-176. https:\/\/doi.org\/10.1016\/j.ajpath.2018.08.019 PMID:30312580","DOI":"10.1016\/j.ajpath.2018.08.019"},{"key":"20755","doi-asserted-by":"crossref","unstructured":"Dai H, Hou K, Cai Z, et al. Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression. Oncol Lett. 2017;14(6):6708-6714. https:\/\/doi.org\/10.3892\/ol.2017.7032 PMID:29391877","DOI":"10.3892\/ol.2017.7032"},{"key":"20756","doi-asserted-by":"crossref","unstructured":"Darvishi N, Rahimi K, Mansouri K, et al. MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression. Mol Cell Probes. 2020;53:101649. https:\/\/doi.org\/10.1016\/j.mcp.2020.101649 PMID:32777446","DOI":"10.1016\/j.mcp.2020.101649"},{"key":"20757","doi-asserted-by":"crossref","unstructured":"Sun XH, Geng XL, Zhang J, et al. miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2). Tumor Biology. 2015;36(3):2127\u20132134 https:\/\/doi.org\/10.1007\/s13277-014-2822-z","DOI":"10.1007\/s13277-014-2822-z"},{"key":"20758","doi-asserted-by":"crossref","unstructured":"Zhang P, Tang WM, Zhang H, et al. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Br J Cancer. 2017;117(4):525-534. https:\/\/doi.org\/10.1038\/bjc.2017.181 PMID:28632723","DOI":"10.1038\/bjc.2017.181"},{"key":"20759","doi-asserted-by":"crossref","unstructured":"Gibriel AA, Abou-Elew MH, Masmoudi S. Analysis of p.Gly12Valfs*2, p.Trp24* and p.Trp77Arg mutations in GJB2 and p.Arg81Gln variant in LRTOMT among non syndromic hearing loss Egyptian patients: implications for genetic diagnosis. Mol Biol Rep. 2019;46(2):2139-2145. https:\/\/doi.org\/10.1007\/s11033-019-04667-0 PMID:30730013","DOI":"10.1007\/s11033-019-04667-0"},{"key":"20760","doi-asserted-by":"crossref","unstructured":"Gibriel AAY, Tate RJ, Yu Y, et al. The p.Arg86Gln change in GARP2 (glutamic acid-rich protein-2) is a common West African-related polymorphism. Gene. 2013;515(1):155-158. https:\/\/doi.org\/10.1016\/j.gene.2012.11.005 PMID:23201897","DOI":"10.1016\/j.gene.2012.11.005"},{"key":"20761","doi-asserted-by":"crossref","unstructured":"Schmittgen TD. Real-time quantitative PCR. Methods. 2001;25(4):383-385. https:\/\/doi.org\/10.1006\/meth.2001.1260 PMID:11846607","DOI":"10.1006\/meth.2001.1260"},{"key":"20762","doi-asserted-by":"crossref","unstructured":"Shatta MA, El-Derany MO, Gibriel AA, El-Mesallamy HO. Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro. Mol Cell Biochem. 2023;478(8):1689-1704. https:\/\/doi.org\/10.1007\/s11010-022-04619-6 PMID:36495373","DOI":"10.1007\/s11010-022-04619-6"},{"key":"20763","doi-asserted-by":"crossref","unstructured":"Abo-Salem HM, Gibriel AA, El Awady ME, et al. Synthesis, molecular docking and biological evaluation of novel flavone derivatives as potential anticancer agents targeting Akt. Med Chem. 2021;17(2):158-170. https:\/\/doi.org\/10.2174\/18756638MTA1vMDUy1 PMID:32141421","DOI":"10.2174\/18756638MTA1vMDUy1"},{"key":"20764","doi-asserted-by":"crossref","unstructured":"Sochor M, Basova P, Pesta M, et al. Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer. 2014;14(1):448. https:\/\/doi.org\/10.1186\/1471-2407-14-448 PMID:24938880","DOI":"10.1186\/1471-2407-14-448"},{"key":"20765","doi-asserted-by":"crossref","unstructured":"Gibriel AA, Al-Anany AM, Al-Arab MAE, Azzazy HME. Investigating circulatory microRNA expression profiles in Egyptian patients infected with hepatitis C virus mediated hepatic disorders. Meta Gene. 2020;26:100792. https:\/\/doi.org\/10.1016\/j.mgene.2020.100792","DOI":"10.1016\/j.mgene.2020.100792"},{"key":"20766","doi-asserted-by":"crossref","unstructured":"Abdulrazaq ZA, Al-Ouqaili MTS, Talib NM. The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: molecular and cytogenetic study. Saudi J Biol Sci. 2024;31(1):103882. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103882 PMID:38125732","DOI":"10.1016\/j.sjbs.2023.103882"},{"key":"20767","doi-asserted-by":"crossref","unstructured":"Bahar NAHA, Al-Ouqaili MTS, Talib NM. Molecular, cytogenetic, and hematological monitoring and response to treatment for chronic myeloid leukemia patients. Al- Anbar Med J (Ft Sam Houst, Tex). 2024;20(2):218-223. https:\/\/doi.org\/10.33091\/amj.2024.152377.1837","DOI":"10.33091\/amj.2024.152377.1837"},{"key":"20768","doi-asserted-by":"crossref","unstructured":"Abdulrazaq ZA, Salih Al-Ouqaili MT, Talib NM. Association between circulating 25-hydroxy vitamin D receptor and molecular response in multiple myeloma. Pak J Biol Sci. 2023;26(9):472-481. https:\/\/doi.org\/10.3923\/pjbs.2023.472.481 PMID:38044697","DOI":"10.3923\/pjbs.2023.472.481"},{"key":"20769","doi-asserted-by":"crossref","unstructured":"Ben Ayed I, Ouarda W, Frikha F, et al. SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition. Am J Med Genet A. 2021;185(4):1081-1090. https:\/\/doi.org\/10.1002\/ajmg.a.62065 PMID:33403770","DOI":"10.1002\/ajmg.a.62065"},{"key":"20770","doi-asserted-by":"crossref","unstructured":"Gibriel AAY. Options available for labelling nucleic acid samples in DNA microarray-based detection methods. Brief Funct Genomics. 2012;11(4):311-318. https:\/\/doi.org\/10.1093\/bfgp\/els015 PMID:22510454","DOI":"10.1093\/bfgp\/els015"},{"key":"20771","doi-asserted-by":"crossref","unstructured":"Lyu L, Wang M, Zheng Y, et al. Overexpression of fam234b predicts poor prognosis in patients with luminal breast cancer. Cancer Manag Res. 2020;12:12457-12471. https:\/\/doi.org\/10.2147\/CMAR.S280009 PMID:33299353","DOI":"10.2147\/CMAR.S280009"},{"key":"20772","doi-asserted-by":"crossref","unstructured":"Lin MF, Yang YF, Peng ZP, et al. FOXK2, regulated by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma. Int J Biochem Cell Biol. 2017;88:155-161. https:\/\/doi.org\/10.1016\/j.biocel.2017.05.019 PMID:28506857","DOI":"10.1016\/j.biocel.2017.05.019"},{"key":"20773","doi-asserted-by":"crossref","unstructured":"Han FJ, Li J, Shen Y, et al. microRNA-1271-5p\/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway. J Ovarian Res. 2020;13(1):110. https:\/\/doi.org\/10.1186\/s13048-020-00720-w PMID:32948241","DOI":"10.1186\/s13048-020-00720-w"},{"key":"20774","unstructured":"Du HY, Liu B. MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1. Eur Rev Med Pharmacol Sci. 2018;22(9):2697-2706. https:\/\/doi.org\/10.26355\/eurrev_201805_14966 PMID:29771421"},{"key":"20775","doi-asserted-by":"crossref","unstructured":"Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37(11):460-465. https:\/\/doi.org\/10.1016\/j.tibs.2012.08.003 PMID:22944280","DOI":"10.1016\/j.tibs.2012.08.003"},{"key":"20776","doi-asserted-by":"crossref","unstructured":"Yu X, Odenthal M, Fries JWU. Exosomes as miRNA carriers: formation\u2013function\u2013future. Int J Mol Sci. 2016;17(12): 2028. https:\/\/doi.org\/10.3390\/ijms17122028","DOI":"10.3390\/ijms17122028"},{"key":"20777","doi-asserted-by":"crossref","unstructured":"Pan Y, Chen Y, Ma D, et al. miR-646 is a key negative regulator of EGFR pathway in lung cancer. Exp Lung Res. 2016;42(6):286-295. https:\/\/doi.org\/10.1080\/01902148.2016.1207726 PMID:27462913","DOI":"10.1080\/01902148.2016.1207726"},{"key":"20778","doi-asserted-by":"crossref","unstructured":"Zhang Z, Ren L, Zhao Q, et al. TRPC1 exacerbate metastasis in gastric cancer via ciRS-7\/miR-135a-5p\/TRPC1 axis. Biochem Biophys Res Commun. 2020e;529(1):85-90. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.181 PMID:32560824","DOI":"10.1016\/j.bbrc.2020.05.181"},{"key":"20779","doi-asserted-by":"crossref","unstructured":"Pan J, Xu X, Wang G. lncRNA ZFAS1 is involved in the proliferation, invasion and metastasis of prostate cancer cells through competitively binding to miR-135a-5p. Cancer Manag Res. 2020;12:1135-1149. https:\/\/doi.org\/10.2147\/CMAR.S237439 PMID:32104094","DOI":"10.2147\/CMAR.S237439"}],"container-title":["Journal of Circulating Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/jcb\/article\/download\/3840\/5307","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/jcb\/article\/download\/3840\/5308","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/jcb\/article\/download\/3840\/5302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/jcb\/article\/download\/3840\/5307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:13:46Z","timestamp":1789542826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.aboutscience.eu\/index.php\/jcb\/article\/view\/3840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,26]]}},"URL":"https:\/\/doi.org\/10.33393\/jcb.2026.3840","relation":{},"ISSN":["1849-4544","1849-4544"],"issn-type":[{"value":"1849-4544","type":"electronic"},{"value":"1849-4544","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}